Cargando…
Thalidomide—Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses
Thalidomide was initially developed as a sedative; subsequently, its use was expanded to treat morning sickness in pregnant women. However, it was later discovered to be a teratogenic drug that was associated with embryopathy in women. A woman is described who was exposed to thalidomide in utero. Sh...
Autores principales: | Malik, Sara, Cohen, Philip R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428198/ https://www.ncbi.nlm.nih.gov/pubmed/34522548 http://dx.doi.org/10.7759/cureus.17070 |
Ejemplares similares
-
SAT678 Metabolic Disorders In Thalidomide Embryopathy
por: Tanabe, Akiyo
Publicado: (2023) -
Quality of life and pain in patients with thalidomide embryopathy in Japan
por: Imai, Koubun, et al.
Publicado: (2020) -
Peripheral Nerve Dysfunction in Middle-Aged Subjects Born with Thalidomide Embryopathy
por: Nicotra, Alessia, et al.
Publicado: (2016) -
Epidemiological Surveillance of Birth Defects Compatible with Thalidomide Embryopathy in Brazil
por: Vianna, Fernanda Sales Luiz, et al.
Publicado: (2011) -
CRL4-Cereblon complex in Thalidomide Embryopathy: a translational investigation
por: Kowalski, Thayne Woycinck, et al.
Publicado: (2020)